SearcharxivSearch

arXiv subjects

Carolus Vitalis

Publications and source records attributed to Carolus Vitalis.

2 recordsLinked to original sources

A decade of SBOL Visual: growing adoption of a diagram standard for engineering biology

Standards play a crucial role in ensuring consistency, interoperability, and efficiency of communication across various disciplines. In the field of synthetic biology, the Synthetic Biology Open Language (SBOL) Visual standard was introduced in 2013 to establish a structured framework for visually representing genetic designs. Over the past decade, SBOL Visual has evolved from a simple set of 21 glyphs into a comprehensive diagrammatic language for biological designs. This perspective reflects on the first ten years of SBOL Visual, tracing its evolution from inception to version 3.0. We examine the standard's adoption over time, highlighting its growing use in scientific publications, the development of supporting visualization tools, and ongoing efforts to enhance clarity and accessibility in communicating genetic design information. While trends in adoption show steady increases, achieving full compliance and use of best practices will require additional efforts. Looking ahead, the continued refinement of SBOL Visual and broader community engagement will be essential to ensuring its long-term value as the field of synthetic biology develops.

q-bio.OT

Leveraging Interactions in Microfluidic Droplets for Enhanced Biotechnology Screens

Microfluidic droplet screens serve as an innovative platform for high-throughput biotechnology, enabling significant advancements in discovery, product optimization, and analysis. This review sheds light on the emerging trend of interaction assays in microfluidic droplets, underscoring the unique suitability of droplets for these applications. Encompassing a diverse range of biological entities such as antibodies, enzymes, DNA, RNA, various microbial and mammalian cell types, drugs, and other molecules, these assays demonstrate their versatility and scope. Recent methodological breakthroughs have escalated these screens to novel scales of bioanalysis and biotechnological product design. Moreover, we highlight pioneering advancements that extend droplet-based screens into new domains: cargo delivery within human bodies, application of synthetic gene circuits in natural environments, 3D-printing, and the development of droplet structures responsive to environmental signals. The potential of this field is profound and only set to increase.

q-bio.QM